Ablation of the locus coeruleus increases oxidative stress in Tg-2576 transgenic but not wild-type mice

International Journal of Alzheimer's Disease

Volumn , Issue , 2010, Pages

  Hurko, Orest ^a,b   Boudonck, Kurt ^c,d   Gonzales, Cathleen ^e   Hughes, Zoe A ^e   Jacobsen, J Steve ^f   Reinhart, Peter H ^f,g   Crowther, Daniel ^h  

^a Biologics Consulting Group Inc   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c METABOLON INC   (United States)

^d BAYER CROPSCIENCE   (United States)

^e PFIZER INC   (United States)

^f Proteostasis Therapeutics   (United States)

^g DUKE UNIVERSITY   (United States)

^h PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN TISSUE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ENERGY METABOLISM; LOCUS CERULEUS; METABOLITE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

EID: 78349234309     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2010/864625     Document Type: Article

References (84)

1. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G., Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice Science 1996 274 5284 99 102
2. Cai X.-D., Golde T. E., Younkin S. G., Release of excess amyloid protein from a mutant amyloid protein precursor Science 1993 259 5094 514 516
3. Cai X.-D., Golde T. E., Younkin S. G., Release of excess amyloid protein from a mutant amyloid protein precursor Science 1993 259 5094 514 516
4. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G., Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice Science 1996 274 5284 99 102
5. Riley K. P., Snowdon D. A., Desrosiers M. F., Markesbery W. R., Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study Neurobiology of Aging 2005 26 3 341 347
6. Iacono D., Markesbery W. R., Gross M., Pletnikova O., Rudow G., Zandi P., Troncoso J. C., The nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life Neurology 2009 73 9 665 673
7. Fernando M. S., Ince P. G., Vascular pathologies and cognition in a population-based cohort of elderly people Journal of the Neurological Sciences 2004 226 1-2 13 17
8. Andersen J. K., Oxidative stress in neurodegeneration: cause or consequence? Nature Medicine 2004 10 S18 S25
9. Baldeiras I., Santana I., Proena M. T., Garrucho M. H., Pascoal R., Rodrigues A., Duro D., Oliveira C. R., Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease Journal of Alzheimer's Disease 2008 15 1 117 128
10. De La Monte S. M., Wands J. R., Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease Journal of Alzheimer's Disease 2006 9 2 167 181
11. Keller J. N., Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease Journal of Biomedicine and Biotechnology 2006 2006
12. Hoyer S., Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease Acta Neurologica Scandinavica, Supplement 1996 93 165 18 24 (Pubitemid 26143163)
13. Kim T.-S., Pae C.-U., Yoon S.-J., Jang W.-Y., Lee N. J., Kim J.-J., Lee S.-J., Lee C., Paik I.-H., Lee C.-U., Decreased plasma antioxidants in patients with Alzheimer's disease International Journal of Geriatric Psychiatry 2006 21 4 344 348
14. Lovell M. A., Markesbery W. R., Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease Nucleic Acids Research 2007 35 22 7497 7504
15. Lovell M. A., Markesbery W. R., Oxidative damage in mild cognitive impairment and early Alzheimer's disease Journal of Neuroscience Research 2007 85 14 3036 3040
16. Markesbery W. R., Lovell M. A., Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment Archives of Neurology 2007 64 7 954 956
17. Mecocci P., Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum Journal of Alzheimer's Disease 2004 6 2 159 163
18. Mosconi L., Pupi A., De Leon M. J., Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease Annals of the New York Academy of Sciences 2008 1147 180 195
19. Petersen R. B., Nunomura A., Lee H.-G., Casadesus G., Perry G., Smith M. A., Zhu X., Signal transduction cascades associated with oxidative stress in Alzheimer's disease Journal of Alzheimer's Disease 2007 11 2 143 152
20. Schulz J. B., Lindenau J., Seyfried J., Dichgans J., Glutathione, oxidative stress and neurodegeneration European Journal of Biochemistry 2000 267 16 4904 4911
21. Su B., Wang X., Nunomura A., Moreira P. I., Lee H.-G., Perry G., Smith M. A., Zhu X., Oxidative stress signaling in Alzheimer's disease Current Alzheimer Research 2008 5 6 525 532
22. Wright A. F., Jacobson S. G., Cideciyan A. V., Roman A. J., Shu X., Vlachantoni D., McInnes R. R., Riemersma R. A., Lifespan and mitochondrial control of neurodegeneration Nature Genetics 2004 36 11 1153 1158
23. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., Cooper N. R., Eikelenboom P., Emmerling M., Fiebich B. L., Finch C. E., Frautschy S., Griffin W. S. T., Hampel H., Hull M., Landreth G., Lue L.-F., Mrak R., MacKenzie I. R., McGeer P. L., O'Banion M. K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F. L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T., Inflammation and Alzheimer's disease Neurobiology of Aging 2000 21 3 383 421
24. Yao Y., Chinnici C., Tang H., Trojanowski J. Q., Lee V. M. Y., Pratic D., Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis Journal of Neuroinflammation 2004 1
25. Karuppagounder S. S., Xu H., Shi Q., Chen L. H., Pedrini S., Pechman D., Baker H., Beal M. F., Gandy S. E., Gibson G. E., Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model Neurobiology of Aging 2009 30 10 1587 1600
26. Resende R., Moreira P. I., Proena T., Deshpande A., Busciglio J., Pereira C., Oliveira C. R., Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease Free Radical Biology and Medicine 2008 44 12 2051 2057
27. Lee K.-W., Kim J.-B., Seo J.-S., Kim T.-K., Im J.-Y., Baek I.-S., Kim K.-S., Lee J.-K., Han P.-L., Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress Journal of Neurochemistry 2009 108 1 165 175
28. Dumont M., Wille E., Stack C., Calingasan N. Y., Beal M. F., Lin M. T., Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease The FASEB Journal 2009 23 8 2459 2466
29. Butterfield D. A., Galvan V., Lange M. B., Tang H., Sowell R. A., Spilman P., Fombonne J., Gorostiza O., Zhang J., Sultana R., Bredesen D. E., In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid -peptide of APP Free Radical Biology and Medicine 2009 48 1 136 144
30. Mann D. M. A., Lincoln J., Yates P. O., Changes in the monoamine containing neurones of the human CNS in senile dementia British Journal of Psychiatry 1980 136 6 533 541
31. Tomlinson B. E., Irving D., Blessed G., Cell loss in the locus coeruleus in senile dementia of Alzheimer type Journal of the Neurological Sciences 1981 49 3 419 428
32. Mann D. M. A., Yates P. O., Hawkes J., The pathology of the human locus ceruleus Clinical Neuropathology 1983 2 1 1 7
33. Mann D. M. A., Yates P. O., Marcyniuk B., A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease Journal of Neurology Neurosurgery and Psychiatry 1984 47 2 201 203
34. Bondareff W., Mountjoy C. Q., Roth M., Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia Neurology 1982 32 2 164 168
35. Ichimiya Y., Arai H., Kosaka K., Iizuka R., Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia Acta Neuropathologica 1986 70 2 112 116
36. Chan-Palay V., Asan E., Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and Parkinson's disease with and without dementia and depression Journal of Comparative Neurology 1989 287 3 373 392
37. Chan-Palay V., Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease Progress in Brain Research 1991 88 625 630
38. German D. C., Manaye K. F., White C. L. III, Woodward D. J., McIntire D. D., Smith W. K., Kalaria R. N., Mann D. M. A., Disease-specific patterns of locus coeruleus cell loss Annals of Neurology 1992 32 5 667 676
39. Nazarali A. J., Reynolds G. P., Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study Cellular and Molecular Neurobiology 1992 12 6 581 587
40. Zarow C., Lyness S. A., Mortimer J. A., Chui H. C., Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases Archives of Neurology 2003 60 3 337 341
41. Adolfsson R., Gottfries C. G., Roos B. E., Winblad B., Changes in the brain catecholamines in patients with dementia of Alzheimer type British Journal of Psychiatry 1979 135 3 216 223
42. Heneka M. T., Galea E., Gavriluyk V., Dumitrescu-Ozimek L., Daeschner J., O'Banion M. K., Weinberg G., Klockgether T., Feinstein D. L., Noradrenergic depletion potentiates -amyloid-induced cortical inflammation: implications for Alzheimer's disease Journal of Neuroscience 2002 22 7 2434 2442
43. Feinstein D. L., Heneka M. T., Gavrilyuk V., Dello Russo C., Weinberg G., Galea E., Noradrenergic regulation of inflammatory gene expression in brain Neurochemistry International 2002 41 5 357 365
44. Heneka M. T., Gavrilyuk V., Landreth G. E., O'Banion M. K., Weinberg G., Feinstein D. L., Noradrenergic depletion increases inflammatory responses in brain: effects on I B and HSP70 expression Journal of Neurochemistry 2003 85 2 387 398
45. Heneka M. T., Ramanathan M., Jacobs A. H., Dumitrescu-Ozimek L., Bilkei-Gorzo A., Debeir T., Sastre M., Galldiks N., Zimmer A., Hoehn M., Heiss W.-D., Klockgether T., Staufenbiel M., Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice Journal of Neuroscience 2006 26 5 1343 1354
46. Kalaria R. N., Stockmeier C. A., Harik S. I., Brain microvessels are innervated by locus ceruleus noradrenergic neurons Neuroscience Letters 1989 97 1-2 203 208
47. Jonnson G., Hallman H., Fonzio F., Ross S., DSP4 (N-(2-chloroethyl)-N- (ethyl-2-bromobenzylamine)a useful dennervation tool for central and peripheral noradrenalin neurons European Journal of Pharmacology 1981 72 2-3 173 188
48. Landa M. E., Rubio M. C., Jaim-Etcheverry G., The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [ 3H ]norepinephrine from rat cortical slices Journal of Pharmacology and Experimental Therapeutics 1984 231 1 131 136
49. Boudonck K. J., Mitchell M. W., Nmet L., Keresztes L., Nyska A., Shinar D., Rosenstock M., Discovery of metabolomics biomarkers for early detection of nephrotoxicity Toxicologic Pathology 2009 37 3 280 292
50. Boudonck K. J., Rose D. J., Karoly E. D., Lee D. P., Lawton K. A., Lapinskas P. J., Metabolomics for early detection of drug-induced kidney injury: review of current status Bioanalysis 2009 1 1645 1663
51. Evans A. M., DeHaven C. D., Barrett T., Mitchell M., Milgram E., Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems Analytical Chemistry 2009 81 16 6656 6667
52. Benjamini Y., Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing Journal of the Royal Statistical Society: Series B 1995 57 289 300
53. Storey J. D., Tibshirani R., Statistical significance for genomewide studies Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9440 9445
54. Pearson K., On lines and planes of closest fit to systems of points in space Philosophical Magazine 1901 2 559 572
55. Gottfries J., Sjgren M., Holmberg B., Rosengren L., Davidsson P., Blennow K., Proteomics for drug target discovery Chemometrics and Intelligent Laboratory Systems 2004 73 1 47 53
56. Palekar A. G., Tate S. S., Meister A., Formation of 5 oxoproline from glutathione in erythrocytes by the glutamyltranspeptidase cyclotransferase pathway Proceedings of the National Academy of Sciences of the United States of America 1974 71 2 293 297
57. Wang W., Ballatori N., Endogenous glutathione conjugates: occurrence and biological functions Pharmacological Reviews 1998 50 3 335 355
58. Visvikis A., Thioudellet C., Oster T., Fournel-Gigleux S., Wellman M., Siest G., High-level expression of enzymatically active mature human -glutamyltransferase in transgenic V79 Chinese hamster cells Proceedings of the National Academy of Sciences of the United States of America 1991 88 16 7361 7365
59. Lieberman M. W., Wiseman A. L., Shi Z.-Z., Carter B. Z., Barrios R., Ou C.-N., Chvez-Barrios P., Wang Y., Habib G. M., Goodman J. C., Huang S. L., Lebovitz R. M., Matzuk M. M., Growth retardation and cysteine deficiency in -glutamyl transpeptidase-deficient mice Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7923 7926
60. Lying-Tunell U., Lindblad B. S., Malmlund H. O., Persson B., Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids. II. Presenile dementia and normal-pressure hydrocephalus Acta Neurologica Scandinavica 1981 63 6 337 350
61. Schulz J. B., Lindenau J., Seyfried J., Dichgans J., Glutathione, oxidative stress and neurodegeneration European Journal of Biochemistry 2000 267 16 4904 4911
62. Vitvitsky V., Thomas M., Ghorpade A., Gendelman H. E., Banerjee R., A functional transsulfuration pathway in the brain links to glutathione homeostasis Journal of Biological Chemistry 2006 281 47 35785 35793
63. Tohgi H., Abe T., Takahashi S., Kikuchi T., The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease Journal of Neural Transmission: Parkinson's Disease and Dementia Section 1993 6 2 119 126
64. Kontush A., Schekatolina S., Vitamin E in neurodegenerative disorders: Alzheimer's disease Annals of the New York Academy of Sciences 2004 1031 249 262
65. Kawarabayashi T., Younkin L. H., Saido T. C., Shoji M., Ashe K. H., Younkin S. G., Age-dependent changes in brain, CSF, and plasma amyloid protein in the Tg2576 transgenic mouse model of Alzheimer's disease Journal of Neuroscience 2001 21 2 372 381
66. Wamelink M. M. C., Struys E. A., Jakobs C., The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review Journal of Inherited Metabolic Disease 2008 31 6 703 717
67. Russell R. L., Siedlak S. L., Raina A. K., Bautista J. M., Smith M. A., Perry G., Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease Archives of Biochemistry and Biophysics 1999 370 2 236 239
68. Kusmierz J., DeGeorge J. J., Sweeney D., May C., Rapoport S. I., Quantitative analysis of polyols in human plasma and cerebrospinal fluid Journal of Chromatography: Biomedical Applications 1989 497 39 48
69. Palmer A. M., The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease Journal of Neural Transmission 1999 106 3-4 317 328
70. Meier-Ruge W., Bertoni-Freddari C., The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease Reviews in the Neurosciences 1996 7 1 1 19
71. Bigl M., Apelt J., Eschrich K., Schliebs R., Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology Journal of Neural Transmission 2003 110 1 77 94
72. Mastrogiacomo F., Bergeron C., Kish S. J., Brain -ketoglutarate dehydrogenase complex activity in Alzheimer's disease Journal of Neurochemistry 1993 61 6 2007 2014
73. Gibson G. E., Blass J. P., Beal M. F., Bunik V., The -ketoglutarate- dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration Molecular Neurobiology 2005 31 13 43 63
74. Gibson G. E., Zhang H., Sheu K. F.-R., Bogdanovich N., Lindsay J. G., Lannfelt L., Vestling M., Cowburn R. F., -ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation Annals of Neurology 1998 44 4 676 681
75. Bubber P., Haroutunian V., Fisch G., Blass J. P., Gibson G. E., Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Annals of Neurology 2005 57 5 695 703
76. Wallin A., Gottfries C. G., Karlsson I., Svennerholm L., Decreased myelin lipids in Alzheimer's disease and vascular dementia Acta Neurologica Scandinavica 1989 80 4 319 323
77. Gottfries C.-G., Karlsson I., Svennerholm L., Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type International Psychogeriatrics 1996 8 3 365 372
78. Fernndez A., Llacuna L., Fernndez-Checa J. C., Colell A., Mitochondrial cholesterol loading exacerbates amyloid peptide-induced inflammation and neurotoxicity Journal of Neuroscience 2009 29 20 6394 6405
79. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., Markesbery W. R., Regional membrane phospholipid alterations in Alzheimer's disease Neurochemical Research 1998 23 1 81 88 (Pubitemid 28145695)
80. Patil S., Chan C., Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons Neuroscience Letters 2005 384 3 288 293
81. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 1991 82 4 239 259
82. Moreira P. I., Sayre L. M., Zhu X., Nunomura A., Smith M. A., Perry G., Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease Methods in Molecular Biology 2010 610 419 434
83. Irizarry M. C., Yao Y., Hyman B. T., Growdon J. H., Pratic D., Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease Neurodegenerative Diseases 2007 4 6 403 405
84. Butterfield D. A., Reed T. T., Perluigi M., De Marco C., Coccia R., Keller J. N., Markesbery W. R., Sultana R., Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease Brain Research 2007 1148 1 243 248